IL111036A - Beta-alanine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same - Google Patents
Beta-alanine derivatives processes for the preparation thereof and pharmaceutical compositions containing the sameInfo
- Publication number
- IL111036A IL111036A IL11103694A IL11103694A IL111036A IL 111036 A IL111036 A IL 111036A IL 11103694 A IL11103694 A IL 11103694A IL 11103694 A IL11103694 A IL 11103694A IL 111036 A IL111036 A IL 111036A
- Authority
- IL
- Israel
- Prior art keywords
- beta
- preparation
- same
- pharmaceutical compositions
- alanine derivatives
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical class NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 210000001772 blood platelet Anatomy 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- 102000008946 Fibrinogen Human genes 0.000 abstract 1
- 108010049003 Fibrinogen Proteins 0.000 abstract 1
- 102000003886 Glycoproteins Human genes 0.000 abstract 1
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 238000004220 aggregation Methods 0.000 abstract 1
- 230000002776 aggregation Effects 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940012952 fibrinogen Drugs 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL12682594A IL126825A (en) | 1993-09-22 | 1994-09-22 | beta-Alanine drivatives processes for their preparation and pharmaceutical compositions containing them |
| IL12682598A IL126825A0 (en) | 1993-09-22 | 1998-10-30 | Beta-alanine derivatives processes for their preparation and pharmaceutical compositions containing them |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939319561A GB9319561D0 (en) | 1993-09-22 | 1993-09-22 | Beta-alanine derivative and a process for preparation thereof |
| GB9413936A GB9413936D0 (en) | 1994-07-11 | 1994-07-11 | Beta-Alanine derivative and a process for the preparation thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL111036A0 IL111036A0 (en) | 1994-11-28 |
| IL111036A true IL111036A (en) | 1999-07-14 |
Family
ID=26303555
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11103694A IL111036A (en) | 1993-09-22 | 1994-09-22 | Beta-alanine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same |
| IL12682594A IL126825A (en) | 1993-09-22 | 1994-09-22 | beta-Alanine drivatives processes for their preparation and pharmaceutical compositions containing them |
| IL12682598A IL126825A0 (en) | 1993-09-22 | 1998-10-30 | Beta-alanine derivatives processes for their preparation and pharmaceutical compositions containing them |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12682594A IL126825A (en) | 1993-09-22 | 1994-09-22 | beta-Alanine drivatives processes for their preparation and pharmaceutical compositions containing them |
| IL12682598A IL126825A0 (en) | 1993-09-22 | 1998-10-30 | Beta-alanine derivatives processes for their preparation and pharmaceutical compositions containing them |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6380215B1 (de) |
| EP (2) | EP0669912B1 (de) |
| CN (1) | CN1041919C (de) |
| AT (1) | ATE210118T1 (de) |
| AU (1) | AU684547B2 (de) |
| CA (1) | CA2157792C (de) |
| DE (1) | DE69429328T2 (de) |
| DK (1) | DK0669912T3 (de) |
| ES (1) | ES2164109T3 (de) |
| HU (1) | HUT73174A (de) |
| IL (3) | IL111036A (de) |
| PT (1) | PT669912E (de) |
| RU (1) | RU2161155C2 (de) |
| TW (1) | TW401414B (de) |
| WO (1) | WO1995008536A1 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010051730A1 (en) * | 1993-09-22 | 2001-12-13 | Fujisawa Pharmaceutical Co., Ltd. | Beta-alanine derivative and a process for the preparation thereof |
| CA2215106A1 (en) * | 1995-03-17 | 1996-09-26 | Fujisawa Pharmaceutical Co., Ltd. | N-acylpiperidinylcarbonylaminocarboxylic acids and their use as glycoprotein iib/iiia antagonists and fibrinogen-blood platelets binding inhibitors |
| KR19990087694A (ko) * | 1996-03-13 | 1999-12-27 | 후지야마 아키라 | 피브리노겐 수용체 길항제로서의 N-[(R)-１-{３-(４-피페리딜)프로피오닐-３-피페리딜카보닐]-２(S)-아세틸아미노-β-알라닌 |
| PT923555E (pt) * | 1996-05-01 | 2005-09-30 | Ortho Mcneil Pharm Inc | Derivados carboxamida de pirrolidina, piperidina e hexa-hidroazepina para o tratamento de disturbios tromboticos |
| EP1184374B1 (de) * | 1996-05-01 | 2009-01-28 | Ortho-McNeil Pharmaceutical, Inc. | Carboxamidderivate von Pyrrolidin, Piperidin und Hexahydropiperizin für Behandlung von Thrombosen |
| EP1000030A1 (de) * | 1997-07-14 | 2000-05-17 | Phytera Symbion ApS | Piperidin-oligomeren und diese enthaltende kombinatorische bibliotheken |
| US6066651A (en) | 1997-10-29 | 2000-05-23 | Ortho-Mcneil Pharmaceutical, Inc. | Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders |
| US6020347A (en) * | 1997-11-18 | 2000-02-01 | Merck & Co., Inc. | 4-substituted-4-piperidine carboxamide derivatives |
| AU1415099A (en) * | 1997-11-18 | 1999-06-07 | Merck & Co., Inc. | 4-substituted-4-piperidine carboxamide derivatives |
| AU769718B2 (en) * | 1998-10-12 | 2004-02-05 | Fujisawa Pharmaceutical Co., Ltd. | New processes for producing beta-alanine derivative |
| AUPP646598A0 (en) * | 1998-10-12 | 1998-11-05 | Fujisawa Pharmaceutical Co., Ltd. | New processes for producing alpha-alanine derivative |
| MXPA01009615A (es) * | 1999-03-22 | 2003-07-21 | Johnson & Johnson | Procedimiento para la preparacion de acido [s -(r*s*)] -°-[[[1[1- oxo-3 -(4-piperidinil) propil]3 -piperidini] carbonil] amino] -3-piridinil] carbonil] amino] -3-piridinpropanoico, y derivados del mismo. |
| DE60021521T4 (de) | 1999-09-29 | 2006-09-21 | Ortho-Mcneil Pharmaceutical, Inc. | Isonipecotamide zur behandlung von integrin vermittelten störungen |
| AUPQ570100A0 (en) * | 2000-02-17 | 2000-03-09 | Fujisawa Pharmaceutical Co., Ltd. | Beta-alanine derivatives and their use as receptor antagonists |
| US7081460B2 (en) | 2001-04-09 | 2006-07-25 | Ortho-Mcneil Pharmaceutical, Inc. | Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| EP2404899A1 (de) | 2004-02-25 | 2012-01-11 | Astellas Pharma Inc. | Kontrastmittel für Thrombusentdeckung |
| US9345793B2 (en) | 2011-08-17 | 2016-05-24 | Piramal Imaging Sa | Compounds for binding to the platelet specific glycoprotein IIB/IIIA and their use for imaging of thrombi |
| CA2900595A1 (en) | 2013-02-12 | 2014-08-21 | Bayer Pharma Aktiengesellschaft | Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia |
| KR102548998B1 (ko) | 2020-03-31 | 2023-06-29 | 재단법인 아산사회복지재단 | 혈전영상을 위한 방사성의약품 및 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03257624A (ja) * | 1990-03-08 | 1991-11-18 | Fujitsu Ltd | 画面言語方式 |
| CA2037153A1 (en) * | 1990-03-09 | 1991-09-10 | Leo Alig | Acetic acid derivatives |
| CA2054627A1 (en) * | 1991-02-13 | 1992-08-14 | Yea-Shun Cheng | Polypeptide skeletal muscle relaxants |
| FI934894A0 (fi) * | 1991-05-07 | 1993-11-05 | Merck & Co Inc | Fibrinogenreceptorantagonister |
| US5770575A (en) * | 1994-03-16 | 1998-06-23 | Ortho Pharmaceutical Corporation | Nipecotic acid derivatives as antithrombotic compounds |
-
1994
- 1994-09-21 RU RU95112456/04A patent/RU2161155C2/ru not_active IP Right Cessation
- 1994-09-21 HU HU9501845A patent/HUT73174A/hu unknown
- 1994-09-21 CA CA002157792A patent/CA2157792C/en not_active Expired - Lifetime
- 1994-09-21 DE DE69429328T patent/DE69429328T2/de not_active Expired - Lifetime
- 1994-09-21 WO PCT/JP1994/001550 patent/WO1995008536A1/en not_active Ceased
- 1994-09-21 PT PT94927076T patent/PT669912E/pt unknown
- 1994-09-21 US US08/495,572 patent/US6380215B1/en not_active Expired - Lifetime
- 1994-09-21 TW TW083108696A patent/TW401414B/zh not_active IP Right Cessation
- 1994-09-21 CN CN94190981A patent/CN1041919C/zh not_active Expired - Fee Related
- 1994-09-21 DK DK94927076T patent/DK0669912T3/da active
- 1994-09-21 AU AU76657/94A patent/AU684547B2/en not_active Ceased
- 1994-09-21 AT AT94927076T patent/ATE210118T1/de not_active IP Right Cessation
- 1994-09-21 ES ES94927076T patent/ES2164109T3/es not_active Expired - Lifetime
- 1994-09-21 EP EP94927076A patent/EP0669912B1/de not_active Expired - Lifetime
- 1994-09-21 EP EP01102827A patent/EP1106606A3/de not_active Withdrawn
- 1994-09-22 IL IL11103694A patent/IL111036A/xx not_active IP Right Cessation
- 1994-09-22 IL IL12682594A patent/IL126825A/xx not_active IP Right Cessation
-
1998
- 1998-10-30 IL IL12682598A patent/IL126825A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK0669912T3 (da) | 2002-03-04 |
| IL111036A0 (en) | 1994-11-28 |
| CN1041919C (zh) | 1999-02-03 |
| WO1995008536A1 (en) | 1995-03-30 |
| EP1106606A3 (de) | 2003-10-22 |
| ATE210118T1 (de) | 2001-12-15 |
| EP0669912B1 (de) | 2001-12-05 |
| EP0669912A1 (de) | 1995-09-06 |
| HK1004985A1 (en) | 1998-12-18 |
| DE69429328D1 (de) | 2002-01-17 |
| DE69429328T2 (de) | 2002-06-13 |
| CA2157792C (en) | 2005-05-24 |
| HU9501845D0 (en) | 1995-08-28 |
| CA2157792A1 (en) | 1995-03-30 |
| EP1106606A2 (de) | 2001-06-13 |
| IL126825A (en) | 1999-09-22 |
| AU7665794A (en) | 1995-04-10 |
| CN1116847A (zh) | 1996-02-14 |
| ES2164109T3 (es) | 2002-02-16 |
| TW401414B (en) | 2000-08-11 |
| AU684547B2 (en) | 1997-12-18 |
| RU2161155C2 (ru) | 2000-12-27 |
| IL126825A0 (en) | 1999-08-17 |
| HUT73174A (en) | 1996-06-28 |
| US6380215B1 (en) | 2002-04-30 |
| RU95112456A (ru) | 1997-04-20 |
| PT669912E (pt) | 2002-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL126825A0 (en) | Beta-alanine derivatives processes for their preparation and pharmaceutical compositions containing them | |
| HU9303145D0 (en) | Process for producing of fibrinogen receptor antagonist compounds and pharmaceutical compositions containing them as medical agent | |
| MX9604378A (es) | Amidas de acido quinolin-2-carboxilico sustituidas, su preparacion y su empleo como medicamentos, asi como productos intermedios. | |
| EA200400432A1 (ru) | Производные мочевины | |
| EA200300776A1 (ru) | Производные фенэтаноламина для лечения респираторных заболеваний | |
| HU229581B1 (en) | Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof | |
| MY123354A (en) | 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives | |
| CA2260016A1 (en) | Substituted pyridines as selective cyclooxygenase-2 inhibitors | |
| CY1111951T1 (el) | Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου | |
| ATE321543T1 (de) | Pharmazeutische zusammensetzungen mit hydroximsäurederivaten | |
| MY128014A (en) | Thiol and thiocarbonyl derivatives which are useful as carboxypeptidase u inhibitors | |
| ES2180564T3 (es) | 2-fenil-3-azoilbenzotiofenos para aumentar la expresion de trombomodulina. | |
| MD1560F2 (en) | Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses. | |
| DE60035429D1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| NO951944D0 (no) | Acylerte aminoalkanimidazoler og -triazoler, fremgangsmåte for deres fremstilling, farmasöytisk preparat inneholdende disse og den terapeutiske anvendelse derav | |
| SE9901572D0 (sv) | New compounds | |
| ZA891769B (en) | Heterocyclic compounds | |
| AP9801417A0 (en) | Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders. | |
| SG146685A1 (en) | Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them | |
| ATE441653T1 (de) | Phosphorenthaltende verbindugnen mit antithrombitische wirkung | |
| MXPA99003849A (es) | Derivados 9a, 11b-deshidro de 9-oxima-3-ceto-6-0-metileritromicina. | |
| MXPA05003633A (es) | 2"-oxo-voruscharina y derivados de la misma. | |
| EP0823254A4 (de) | Neue verwendung von pyrazolopyridinverbindungen | |
| MY135855A (en) | "pyrrolopyrimidinone derivatives, process of preparation and use" | |
| DE69622868D1 (de) | Inhibitoren der blutplättchen-aggregation, die c-terminale aminosäurereste mit aminergen seitenketten enthalten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |